MK-0616 is smashing all competitors for the prevention and treatment of atherosclerosis.
One injection of nirsevimab reliably protects newborns against the development of RSV-associated lower respiratory tract infections.
Novo Nordisk will offer a very patient-friendly weekly version of insulin.
Modern pharmacological ways to combat obesity.
Ublituximab is the third anti-CD20 therapy for multiple sclerosis and a worthy rival to Ocrevus and Kesimpta.
Tirzepatide by Eli Lilly is a powerful new antidiabetic drug.
Sutimlimab will reduce the need for red blood cell transfusion due to hemolysis.